Support for NPR comes from NPR member stations and Eric and Wendy Schmidt through the Schmidt Family Foundation,

working toward a healthy, resilient, secure world for all. On the web at theshmit.org.

Live from NPR News in Washington, I'm Rylan Barton.

U.S. sponsored peace talks between Russia and Ukraine

broke off earlier than expected today in Geneva, Switzerland. However, participants are suggesting

that some progress was made, NPR's Charles Maines reports from Moscow.

The Kremlin's lead negotiator, Vladimir Medinsky, gave no explanation for the abrupt end to the

meetings, described them as difficult and

business-like, and said they would continue at a later date. Ukraine noted progress in negotiations,

a view shared by White House envoy Steve Whitkoff, though neither provided further details.

Negotiations have bogged down over Russian ultimatums, Ukraine's surrender territory, including land not

controlled by Russian forces, as well as Ukraine's demands for ironclad security guarantees

from the U.S. should it even consider a deal.

Ahead of the talks, President Trump said the onus was on Kiev to make concessions, saying

Ukraine better come to the table fast.

Charles Mainz, NPR News, Moscow.

The Food and Drug Administration is reversing course and will consider approving

Mederna's experimental flu shot after all. The decision comes a little more than a week after

the agency refused to review the jab. NPR's Sidney Lupkin has more.

The FDA rattled the biotech industry when it said it wouldn't even look at

Moderna's application to market the first MRNA flu shot.

Moderna used its MRNA technology to swiftly create and manufacture its COVID-19 shot during

...